Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The antibody detects a protein of Candida famata and is useful for detection of candidiasis and retinopathies in samples from blood, urine, aqueous humour, vitreous humour, and cerebral spinal fluid without interference from other species of Candida More
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Photodynamic Therapy of Cervical Cancer, Cervical Dysplasia and HPV Infection More
Glycan Microarray Devices for Quantitative Detection Analysis of Cancer More
Molecular Diagnostics for Breast Cancer Precursors More
Elucidation of a Novel Biomarker to Predict Resistance to Doxorubicin Cancer Therapy More
P38MAPK as a Marker for Predicting Tamoxifen Resistance More
Clinical Applications of Serum HtrA1 as Markers for Pre-Eclampsia, Osteoarthritis and Cardiovascular Diseases More
Biomarkers for Breast Cancer Based on Genetic Instability More
Cervical Cancer Screening: New Diagnostic for the Detection of the HPV E7 Oncoprotein in Cervical Biopsies and in Ectocervical Smears More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2011 - 50 pages - $3,800
Jan 2011 - 45 pages - $5,700
Apr 2011 - 150 pages - $3,995
May 2011 - 102 pages - $3,835
Aug 2007 - 87 pages - $1,999
Sep 2006 - 126 pages - $2,875
Feb 2011 - 22 pages - $99
Apr 2011 - 951 pages - $4,995
Oct 2009 - 141 pages - $3,835
Nov 2010 - 19 pages - $750
Your selection
Browse By
- Therapeutic target
- Amenorrhea
- Contraception, female
- Dysmenorrhea
- Dysoplasia, cervical
- Endometriosis
- Female arousal disorder
- Gynecological disorder (other)
- Menopause
- Pelvic inflammatory disease
- Polycystic ovary syndrome
- Pregnancy
- Sjogren's syndrome
- Turner's syndrome
- Women's health (other)
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us